The Hidden Cost of Drug Billing Errors: Protecting Infusion Center Revenue Through Accurate Medication Reporting
Discover how Drug Billing errors affect infusion reimbursement and how accurate medication reporting helps prevent claim denials and revenue loss.

Infusion centers collaborating with high-cost medications, biologics, and specialty treatments have financial and compliance issues with Drug Billing errors. Mismatched HCPCS codes, dosage calculations, reporting of National Drug Code (NDC) and drug quantities disposed are all impacts on claim accuracy and reimbursement.
One medication discrepancy may lead to underbilling, claim denials, delay in claims payments, and recoupments by Medicare. When billing teams spend multiple times correcting claims and missing medications, these issues cost you more.
A recent federal discovery backs up the need to accurately report medication. In October of 2026, the HHS Office of Inspector General (OIG) released a report that identified 160,918 lines of Medicare outpatient drug claims in which the procedure code was not in CMS’ drug code crosswalk. The wasted expenditure of Medicare Part B on discarded drugs in 2023 was estimated at $934 million according to a June 24, 2026 study published in the Journal of the American Medical Association (JAMA) Network Open.
Medication documentation, drug coding, claim validation for various payers and reliable medication documentation monitoring are all critical elements for infusion centers. A streamlined Drug Billing process, alongside seamless Infusion Revenue Cycle Management, can contribute to meeting these needs throughout the Drug Billing Cycle.
The 2026 Reality: Why Drug Billing Accuracy Matters More Than Ever
Infusion centers have built-in risk management in the form of reporting the accuracy of medications in order to be reimbursed. There are multiple areas of billing exposure that are present in high-cost drugs, changing HCPCS codes, payer specific requirements, and documentation standards.
Infusion providers should analyze their Drug Billing processes and reimbursement controls, right now, because of recent federal insights.
| 2026 Finding | Reported Evidence | Impact on Infusion Centers |
|---|---|---|
| HCPCS and drug code mismatches | An October 2026 OIG report identified 160,918 Medicare outpatient drug claim lines with procedure codes that did not match associated drug codes in CMS crosswalk files. | Highlights weaknesses in medication identification and claim validation. |
| Provider billing oversight | OIG found that Medicare contractors lacked system edits to ensure correct procedure code matching for the reviewed outpatient drug claims. | Reinforces the need for independent coding validation before claim submission. |
| Medicare discarded drug spending | A July 2026 JAMA Network Open study reported $934 million in discarded drug spending during 2023. | Demonstrates the financial significance of medication waste and accurate discarded drug reporting. |
| Long-term discarded drug spending | The same study identified $4.8 billion in cumulative discarded drug spending from 2017 through 2023. | Highlights the importance of medication utilization monitoring and wastage controls. |
| Drug wastage reporting trends | Discarded drug spending represented approximately 1.8% of total Medicare Part B drug spending in 2023. | Shows how a relatively small percentage represents substantial spending across Medicare. |
The findings elaborate other Medicare drug reimbursement issues. OIG findings involve mismatches in outpatient drug coding, while the JAMA study involves money thrown away for drugs. Neither sets a standard rate of drug billing errors in infusion centers.
The OIG report also noted that 99% of the claims to be mismatched to the acronym included claims for outpatient drugs received by CAHs and short-term acute-care hospitals. Every infusion, of course, does not have the same issues, so when these findings emerge, infusion centers should view them as a sign of coding issues, rather than a sign that everyone with an infusion has the same problems.
These figures underline the fact that identification of the medication, correct reporting on claiming the medication, and documentation are crucial. Effective Drug Billing controls improve infusion centers’ chances of detecting discrepancies early on and letting the differences have minimal impact on the reimbursement process.
How Drug Billing Errors Create Hidden Revenue Losses for Infusion Centers
Drug billing errors impact more than one claim payout. They add to administration, slow collections and put infusion centers at risk of having to repay.
The table below illustrates the financial impacts in response to reporting issues.
| Drug Billing Problem | How the Error Occurs | Financial Impact |
|---|---|---|
| Underbilling | Incorrect HCPCS units or dosage calculations. | Lost reimbursement and revenue leakage. |
| Overpayments | Incorrect drug quantities, wastage, or NDC reporting. | Repayments and audit exposure. |
| Claim denials | Incorrect drug codes or missing documentation. | Delayed payments and increased A/R. |
| Billing corrections | Repeated claim reviews, appeals, and reconciliation. | Higher administrative costs and staff workload. |
Many times, these financial consequences can also overlap. A wrong dosage computation could result in the wrong dosage being claimed and a false claim being denied, adding to staff time spent making corrections. Another factor to consider when there are repeated Drug Billing errors is the difficulty in determining the root cause of reimbursement difficulties.
Precise reporting of medication for infusion centers is a critical element of financial management and revenue cycle processes.
Seven Common Drug Billing Errors That Put Infusion Center Revenue at Risk
There are several interconnected billing requirements involved with medication reporting. The few problems associated with drug identification, dosage calculation, documentation and details on the required reimbursement bring different issues of financial and compliance risks into play.
Recognizing these issues can help infusion centers put in place more robust safeguards prior to claims submitting to payers.
Incorrect HCPCS Drug Code Selection
Medicare lists many injectable drugs, biological products and others on the Healthcare Common Procedure Coding System (HCPCS) Level II. If there is a mismatch between the code selected and the code selected for the drug on the claim, it is due to the worker selection of an error.
Common problems include:
- Incorrect selection of a drug specific HCPCS Code.
- Failure to use up to date codes for quarterly updates.
- When a more exact code is available, reporting an unclassified drug when a more specific code is available.
- Not reviewing code descriptions and effective dates.
- Many times, the patient is given the wrong medication instead of the one prescribed.
Billing staff may choose a drug code that is off the mark from an internal drug code reference. The drug given is right, but the claim is an old identifier. This can cause a claim to be denied, payment may be left off, or it can be submitted to the additional payer for review. Drug Billing teams need to have all the coding references in order to prevent these avoidable issues.
How to prevent it: Keep current HCPCS reference files. Before the claim, check to be sure of the medication’s identity, applicable code, descriptor and effective date.
Incorrect Drug Units and Dosage Reporting
A HCPCS billing unit doesn’t necessarily equal proper medication doses, injections, or vials. There is a billing unit for each drug code, and the quantity reported will need to be followed by the drug code’s descriptor. Medication names that are misinterpreted, or medication doses administered as though they were a “unit”, will present the dual hazard of underbilling and overbilling.
Common mistakes include:
- Reporting wrong HCPCS units instead of the required HCPCS units.
- Misinterpreting the dosage unit symbol (e.g., calling pricing both 5 CPH and 5 PPS).
- Administered amount inaccurately reported.
- Not rounding fractional units appropriately, based on guidance, within the number.
- Reporting amounts that are not in line with MAR.
Explanation: Each unit of the drug in the billing is billed according to 10 mg in the HCPCS descriptor. After the dosage is stated in the medical record as 50 mg, there will be a five unit claim, if the individual’s medical code and applicable billing directions support these five units.
The actual amount of medication being administered is not being reported: 50 units would be a misrepresentation of the amount administered and so would be one unit. There should be coordination among medication administration, coding references, clinical documentation to ensure accurate drug billing units.
Prevention: Make sure to check the HCPCS descriptor before performing unit calculations. Compare the prescribed dose, administration of dose, concentration of medication available and documented quantity of medication.
NDC Reporting Errors and HCPCS Mismatches
The National Drug Code describes a particular combination of drug product and package size. Service codes, along with their corresponding code numbers or code letters are called HCPCS codes, and they are assigned to facilitate billing for services/drugs. Numerous identifiers are utilized for different purposes. Care must be taken in verifying their relationship.
The most typical NDC reporting issues are:
- Using another bottle or a different NDC is wrong.
- Using a wrong package specific identifier.
- Reporting a wrong NDC unit of measurement.
- Failing to relate the quantity of packages to the appropriate package size.
- Failing to submit NDC information when it is necessary by the payer.
- Providing medicines data that varies between claim fields.
The differences are even more significant if a drug comes in several manufacturers, packaging sizes or product formats.
Example: The infusion center uses an infusion set from a different manufacturer’s vial with the same NDC code from a different package configuration. A claim submitted does not correctly represent the product given.
How to avoid it: Review and correspond to the NDC with the actual medication administration record and package. Ensure a specific NDC format, unit of measure, quantity, and HCPCS relationship required.
Version 12 of the Medicare Part B NDC-HCPCS crosswalk files are published by CMS in order to facilitate this process. However, if a crosswalk mismatch occurs, it does not automatically mean the claim is incorrect, it should be investigated. Providers are also required to check out coding directions and requirements set by the payer.
Correct NDC validation improves Drug Billing controls to maintain the uniformity of identification of the drug between clinical and financial records.
Incorrect Drug Wastage Reporting
Drug wastage is defined as the loss of drug once you have prepared or given a prescribed dose, whether the medicine is used up or not. Single-dose containers may lead to this circumstance where there is not always an adequate supply of vial doses corresponding to the amount of dosage required by patients.
The wrong reporting exposes two types of financial risk. Infusion centers may end up not claiming reimbursement for products which are discarded or claiming amounts that are not then eligible for reimbursement.
Common mistakes include:
- Adhered to the administration of drugs as a discarded item.
- Using multiple doses from wrappers in a single Medicare container.
- Incorrectly calculating unused quantities.
- Not recording patients’ disposal of medication.
- Use of JW and JZ modifiers incorrectly.
If there is a vial of medicine in the use package, and it is labelled as 100 mg in one dose, then the contents of the vial are adequate for 1 dose. The patient takes 80mg and the other 20mg is given away. There are certain Medicare regulations that need to be met if Medicare’s requirements are followed, and the amounts of administered and eligible discarded materials must be reported.
The quantity discarded, and the quantity administered should coincide with the medication records or applicable unit of billing calculations.
How to avoid it: Note original amount on the vial, amount given, running out of medication, and how much was discarded. Use the proper modifier when using the drug according to the packaging, payment status and applicable payer policy.
Missing Medication Documentation and Medical Necessity
Backend coding is not the key to getting paid if supporting clinical documentation is lacking. Payers must have adequate documentation in order to determine the medication was both prescribed, prescribed for medical necessity and provided in compliance to applicable coverage requirements.
Typical documentation issues are:
- Lack of or incomplete physicians orders.
- Medication Administration Records (no dosage information).
- Missing administration dates.
- Inconsistent medication quantities.
- Not enough notes done in support of the diagnosis and treatment.
- Lacking records required by policies as to coverage.
For instance, information may disclose correct medication and dosage, but the record may not show the amount given or treatment specifics. The insurance company may ask for more paperwork or reject the claim. An extra requirement for drug Billing is clinical record reconciliation prior to claims submission.
How to prevent it: Reconcile physician orders, clinical indications, medication administration records and billing data prior to submission. Make sure that the documentation matches the medication/service billed.
Incorrect Revenue Codes and Drug Claim Classification
The requirements for drug billing vary by hospital outpatient department and physician-office settings. Drugs and biologicals are typically reported in appropriate HCPCS codes and to the appropriate revenue code requirements in hospital outpatient departments. There are numerous hospital outpatient drug claims that use revenue code 0636.
Professional claims are billed according to a different plan. The revenue code rules that apply to hospital claims should not be used automatically on claims submitted from a physician’s office.
Common mistakes include:
- Inaccurate use of hospital outpatient claim revenue codes.
- Reporting drugs without identification of drug controls.
- Failure of the provider to submit the necessary HCPCS information.
- Failing to classify packaged drugs as separate payments.
- Using hospital billing instructions in professional claim.
The errors will impact claims classification and payment calculations. Drug Billing requirements shall be the same as the billing setting and applicable Medicare payment system.
How to prevent it: Be aware of the billing setting, before preparing a claim. Follow the Medicare payment system/claim format used, HCPCS requirements, and payer specific instructions.
Outdated Drug Payment Rates and Reimbursement Information
The payments allowed for drugs through Medicare Part B are subject to quarterly changes. Outdated price data results in errors in reimbursement calculations, and less reliable payment reconciliation.
Common problems include:
- Using an old Average Sales Price (ASP) file.
- Failure to correct limits on quarterly payments.
- Not following applicable NDC-HCPCS crosswalks.
- Incorrectly estimating expected drug reimbursement.
- Avoiding the specifics of the payment method for a particular drug or a particular payer.
For instance, if a new CMS file takes effect for a quarter, yet a billing team is still operating with a limit from an earlier quarter, they will keep working this way. All submitted claims may include correct coding but the calculation for the reimbursement would not reflect the payment period for that coding.
How to prevent it: Review the most recent CMS payment limit files, and applicable Payer fee schedules. Keep a current list of drugs that can be priced and update reimbursement calculations quarterly.
How Drug Wastage and Incorrect Medication Reporting Affect Infusion Profitability
Another financial challenge infusion centers face with wastage is that many drugs in the infusion centers are specialty drugs or biological drugs and they have a high acquisition cost. It is important to note that the prescribed dose will not always be the same as the amount found in a single dose vial. Medication may need to be disposed of following product labelling and safety guidelines and traditions.
Infusion centers can easily differentiate administered drugs from eligible discarded drugs with accurate Drug Billing Records.
Why Single-Dose Vials Create Medication Wastage
Single Dose Containers for a single administration of the patient. The dose given to the patient however may be less than the amount of medicine in the medical vial.
This presents a number of operating issues:
- Dosages may not be exactly that of a typical vial.
- Medication may need to be disposed of if it is not used up.
- Use of higher-cost biologics makes the cost of disposing of unused portions more important.
- Vial utilization is impacted by medication preparation and scheduling.
If the records of wastage aren’t complete, it means there are differences in reimbursement. The above study published in JAMA Network Open in 2026 estimated that $934 million was wasted on Medicare Part B drugs waste in 2023. The amount of drug spending on discarded drug units accounted for about 1.8% of overall Part B drug spending, but the actual spending level for the drug units was significant.
It also identified significant differences between the amount of drug waste among specific drugs. This does not imply that the wastage is the experience of all drug and infusion centers. A single overall wastage percentage should not be used to monitor, rather there should be a monitoring program at the individual drug and treatment level. This data also is beneficial for the Drug Billing teams when it comes to identifying discrepancies between the inventory of medications and when they are submitted in claims.
Medicare JW and JZ Modifier Requirements
JW and JZ modifiers are used by Medicare to flag discarded quantities of the drug and when the drug quantity was not deemed eligible for discard.
| Modifier | Reporting Purpose | Billing Consideration |
|---|---|---|
| JW | Identifies eligible discarded drug amounts. | Report the discarded quantity on a separate claim line when required. |
| JZ | Indicates no discarded drug amount. | Report on applicable claims for separately payable drugs from single-dose containers when no amount was discarded. |
There are a number of important Medicare facts to consider:
JW modifier:
- Knows which discarded quantities are in the containers or from single use packages are eligible.
- Must report the quantity discarded separately.
- Needs documentation in record.
- Never use amounts from multi-dose containers of medication that have been thrown out, even if they still have a lot to be used later.
JZ modifier:
- Means that none of the acceptable dose of any drug was thrown away.
- Covers eligible Medicare Part B medicine claims on single unit containers or single unit packages.
- Should be reported if required as per applicable Medicare policy.
However, Medicare has certain provisions for the case where the administered/discarded quantity is already reflected in the billing unit. If there is an extra JW line report, it might result in duplicate billing and over payment in such situations.
Not all drugs and billing environments are covered by JW/JZ policy. For instance, Medicare does not require any of the modifiers noted above for packaged drugs and drugs that are administered within FQHC and RHC settings.
Care should be taken to examine CMS guidance and relevant policy from payers prior to applying these modifiers. Correct Modifier Reporting is still an integral component in the process of Compliant Drug Billing.
Financial Controls to Reduce Preventable Drug Waste
Infusion centers should integrate stock management and inventory into clinical appointment and billing reconciliation.
Practical controls include:
- Discuss the prescription history of the medicines and the number of vials purchased.
- Monitor levels of the drugs given and the patients who take them.
- Track the disposal of medication by HCPCS code.
- Schedule treatments with other providers where appropriate.
- Check medication stock against recording of medicines of administration.
- History of JW&JZ modifier reporting.
- Consideration of unusual trends and missing information in wastage.
The controls provide management with information about where the medication is being wasted and if the medication is discarded and reported properly. They also provide Drug Billing teams with improved data to uncover under-reported quantities, faulty records, and even potential overpayments.
How Billing Care Solutions Helps Infusion Centers Maintain an Accurate Revenue Cycle
It isn’t just about choosing the right drugs code; there is much more to accurate Drug Billing. There must be a coordinated effort from eligibility verification to prior authorization, coding, charge capture, claim submission and back to eligibility, deny management and accounts receivable at infusion centers.
Billing Care Solutions offers infusion centers with end-to-end infusion revenue cycle management (RCM) services to ease the burden of coordinating these critical functions.
Patient Eligibility and Infusion Drug Authorization
Lack of coverage and authorization issues typically occur before treatment. If the claim does not meet the requirements for coverage, it may be denied for medical necessity and/or authorization.
Billing Care Solutions can assist infusion centers in seven ways:
- Eligibility verification for patient’s insurance.
- WorkSafe Scorecard drug testing due for infusion drug coverage.
- Prior authorization coordination.
- A review of the medications and treatment that have been approved.
- Determining issues with coverage before claims are submitted.
These activities assist in walking patients, medication authorizations and billing information. They also set the groundwork for DWS’s to provide more precise Drug Billing prior to treatment. staff should submit drugs that are coded and accurately charged.
Accurate Drug Coding and Medication Charge Capture
The accurate information from clinical documentation, medication administration, and drug coding references is essential for medication charge capture.
Billing Care Solutions are in support of:
- Medic coding review for HCPCS/CPT codes.
- Drug dosage & billing unit check.
- NDC reporting validation.
- Medication charge capture.
- Administered medication reconciliation with quantities billed.
- Review of drug modifiers and codes.
Avoiding reporting and charge discrepancies by accurately capturing charges, can resolve medication charges that may be missed prior to payment. This helps in facilitating reliable Drug Billing all throughout the claim preparation process.
Infusion Claim Preparation and Submission
A complete infusion claim should accurately represent actual care and medication. Drug identifiers, quantities, modifiers and supporting documentation must be consistent throughout the claim.
Billing Care Solutions also assists in preparing infusion claims via:
- Review of medication coding and billing units.
- Verification of information related to claims; proper documentation.
- Discussion of appropriate revenue code and modifiers.
- Claim requirement checks to be performed by the Payer.
- Claim processing and e-filing of claims.
- Detecting incorrect or partial billing information.
This is a coordinated review that will minimize claim corrections and prevent claim submission mistakes. Clear Drug Billing verification also helps to speed up the initial Drug Claim.
Drug Billing Denial Management and Appeals
Medication denials need investigation from a claim, clinical document, claim coding, authorization and an explanation of benefits from the payer.
Billing Care Solutions helps internal to handle denials by using the following:
- The recognition of drug related denials.
- Investigation of discrepancy in coding and dosage.
- Discussion on authorization/documentation.
- Make claims that are correct and re-submit.
- Appeal preparation and follow-up with payers.
- Tracking reoccurring denial behaviors.
The goal should be to correct the reasons for the denial to avoid similar billing issues. An established denial management can help infusion centers safeguard investor reimbursement and minimize the amount of rework regarding claims that can be a result of multiple claims.
Accounts Receivable and Underpayment Recovery
Infusion claims for people who are under-paid or don’t receive them are tied up in working capital. Disputes for reimbursement costs for high dollar medications warrant timely follow-up as failures to resolve reimbursement issues have a negative impact on financial planning.
Billing Care Solutions contributes to the A/R management in the following ways:
- Tracking claims that are outstanding in the infusion.
- Following up on unpaid and delayed reimbursements.
- Identifying payment discrepancies.
- Auditing contract changes and short-payments.
- Follow up is a priority in the goal of prioritizing aging.
- Monitoring the process of outstanding claims as they are settled.
Having consistent A/R management allows infusion centers to enjoy more visibility of and collection from outstanding revenue. It also identifies reimbursement issues which may warrant additional Drug Billing investigation.
Financial Reporting and Revenue Cycle Performance Monitoring
When it comes to infusion center management, the data is used to manage reimbursement, and to pinpoint issues that may surface time and time again.
Billing Care Solutions helps with financial oversight by offering:
- Drug-related denial tracking.
- Monitoring first pass claim performance.
- A/R aging analysis.
- Underpayment identification.
- Reimbursement trend reviews.
- Revenue Cycle Key Performance Indicators reporting.
These reports assist management to detect billing challenges, track amounts collected and make informed decisions for running the operation. The repetition of Drug Billing performance reviews also contribute to the detection of typical Drug Billing reporting issues.
Complete Infusion RCM With Billing Care Solutions
When billing and payment activities occur in isolation for each other, there are gaps in the authorization process, the reporting of medications, the submission of claims and follow up on payment.
Billing Care Solutions links these together with end-to-end infusion revenue cycle management.
| RCM Service | Billing Care Solutions Support | Operational Objective |
|---|---|---|
| Eligibility verification | Patient insurance coverage checks | Reduce coverage-related billing issues |
| Prior authorization | Medication authorization coordination | Improve authorization compliance |
| Drug coding | HCPCS, CPT, NDC, and dosage validation | Improve medication claim accuracy |
| Charge capture | Medication record reconciliation | Reduce missed drug charges |
| Claim submission | Claim preparation and validation | Reduce preventable submission errors |
| Denial management | Corrections, appeals, and payer follow-up | Strengthen denial recovery |
| A/R management | Outstanding claim and underpayment follow-up | Improve collection performance |
| Financial reporting | Revenue cycle KPI monitoring | Improve financial visibility |
This integrated solution allows infusion centers to manage the complexities of your billing and payment processes by linking clinical information with financial data. Billing Care Solutions can help with the processes all the way from patient eligibility to final reimbursement ensuring an accurate and organized revenue cycle.
Protect Infusion Revenue Through Accurate Drug Billing
The impact of the accuracy of drug billing has dire implications for reimbursements, center expenses, and compliance. Haphazard coding, dosage calculation, NDC reporting and disposal quantities result in unnecessary financial risk.
New federal results highlight the necessity of reporting medications accurately and with documentation. Infusion centers need to have consistently known drug identification, charge capture, claim verification and reimbursement monitoring controls.
But the fact that they are able to code drugs accurately does not guarantee successful reimbursement. Eligibility verification, prior authorization, medical necessity documentation, denial management and A/R follow-up also impacts financial performance.
From enrollment to post-payment, Billing Care Solutions connects with infusion centers to provide end-to-end revenue cycle management for infusion centers. Billing Care Solutions offers expert support throughout the entire infusion billing process with improved drug billing accuracy and consistent revenue cycle management for infusion centers.

